Sequent Scientific Ltd posts consolidated PAT of Rs. 37.22 crores in Q3FY21

SEQUENT SCIENTIFIC LTD. has reported financial results for the period ended December 31, 2020.

Financial Results (Q3 FY20-21) - QoQ Comparison

The company has reported total income of Rs.361.02 crores during the period ended December 31, 2020 as compared to Rs.348.90 crores during the period ended September 30, 2020.

The company has posted net profit / (loss) of Rs.37.22 crores for the period ended December 31, 2020 as against net profit / (loss) of Rs.21.26 crores for the period ended September 30, 2020.

The company has reported EPS of Rs.1.52 for the period ended December 31, 2020 as compared to Rs.0.86 for the period ended September 30, 2020.

Financials	Q3 FY20-21	Q2 FY20-21	% Change
Total Income	₹ 361.02 crs	₹ 348.90 crs	3.47%
Net Profit	₹ 37.22 crs	₹ 21.26 crs	75.07%
EPS	₹ 1.52	₹ 0.86	76.74%

Financial Results (Q3 FY20-21) - YoY Comparison

The company has reported total income of Rs.361.02 crores during the period ended December 31, 2020 as compared to Rs.317.40 crores during the period ended December 31, 2019.

The company has posted net profit / (loss) of Rs.37.22 crores for the period ended December 31, 2020 as against net profit / (loss) of Rs.20.30 crores for the period ended December 31, 2019.

The company has reported EPS of Rs.1.52 for the period ended December 31, 2020 as compared to Rs.0.83 for the period ended December 31, 2019.

Financials	Q3 FY20-21	Q3 FY19-20	% Change
Total Income	₹ 361.02 crs	₹ 317.40 crs	13.74%
Net Profit	₹ 37.22 crs	₹ 20.30 crs	83.35%
EPS	₹ 1.52	₹ 0.83	83.13%

Financial Results (9 Months ended FY 20-21) - YoY Comparison

The company has reported total income of Rs.1021.74 crores during the 9 months period ended December 31, 2020 as compared to Rs.886.92 crores during the 9 months period ended December 31, 2019.

The company has posted net profit / (loss) of Rs.79.40 crores for the 9 months period ended December 31, 2020 as against net profit / (loss) of Rs.53.05 crores for the 9 months period ended December 31, 2019.

The company has reported EPS of Rs.3.22 for the 9 months period ended December 31, 2020 as compared to Rs.2.17 for the 9 months period ended December 31, 2019.

Financials	9 Months ended FY20-21	9 Months ended FY19-20	% Change
Total Income	₹ 1021.74 crs	₹ 886.92 crs	15.2%
Net Profit	₹ 79.40 crs	₹ 53.05 crs	49.67%
EPS	₹ 3.22	₹2.17	48.39%

Commenting on the Company's performance, Manish Gupta, Managing Director stated "We are pleased to report another strong quarter of performance across all key parameters; while revenues have grown 15.5%, the EBITDA has grown by 42% with a 325 bps margin improvement in the first nine months. With a growth of 66% in net profits, the business generated ₹ 1.6 bn in cash from operations enabling us to pare down debt significantly. ROCE of the business now exceeds 21% reflecting our capital efficiency.

For the second successive year, IHS Markit Animal Health chose Alivira as the best company in animal health from India, Middle East and Africa region.

We stay confident of sustaining this momentum for the foreseeable future as we expand our horizons and leverage the expertise and reach of our global Board."

Shares of SEQUENT SCIENTIFIC LTD. was last trading in BSE at Rs.232.25 as compared to the previous close of Rs. 218.9. The total number of shares traded during the day was 214575 in over 3982 trades.

The stock hit an intraday high of Rs. 236.5 and intraday low of 218.75. The net turnover during the day was Rs. 49286402.

Source : Equity Bulls

Keywords